| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/12/2001 | WO2001049846A1 32164 protein, a novel seven transmembrane protein |
| 07/12/2001 | WO2001049845A1 Growth factor splice variant |
| 07/12/2001 | WO2001049844A1 Compositions and methods for gene silencing |
| 07/12/2001 | WO2001049842A2 Mutm orthologue and uses thereof |
| 07/12/2001 | WO2001049840A2 Spf1-related transcription factors |
| 07/12/2001 | WO2001049838A2 Cis-acting regulatory nucleic acid sequences in the parathyroid hormone 3'-untranslated region |
| 07/12/2001 | WO2001049834A2 Preparation of deallergenized patatin proteins and patatin permutein proteins |
| 07/12/2001 | WO2001049833A2 Recombinant pinoresinol/lariciresinol reductase, recombinant dirigent protein, and methods of use |
| 07/12/2001 | WO2001049832A2 Transduction of recombinases for inducible gene targeting |
| 07/12/2001 | WO2001049828A1 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof |
| 07/12/2001 | WO2001049825A1 Methods for protein transfer |
| 07/12/2001 | WO2001049823A2 Assays for detection of bacillus anthracis |
| 07/12/2001 | WO2001049744A1 Mouse g-protein coupled receptor mas |
| 07/12/2001 | WO2001049743A2 Methods of modulation of the immune system |
| 07/12/2001 | WO2001049742A1 Method for making insulin precursors and insulin precursor analogs |
| 07/12/2001 | WO2001049741A2 A process for isolation of osteopontin from milk |
| 07/12/2001 | WO2001049740A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | WO2001049739A1 A new polypeptide-myelin p0 protein 14 and the polynucleotide encoding it |
| 07/12/2001 | WO2001049738A1 A novel polypeptide - human fkbp protein 11 and a polynucleotide encoding the same |
| 07/12/2001 | WO2001049737A1 A novel polypeptide - human latexin protein 46 and a polynucleotide encoding the same |
| 07/12/2001 | WO2001049736A1 A new polypeptide-human rs3 protein and the polynucleotide encoding it |
| 07/12/2001 | WO2001049735A1 A novel polypeptide-human g-protein and the polynucleotide encoding the same |
| 07/12/2001 | WO2001049734A1 A novel polypeptide - plp protein 10 and a polynucleotide encoding the same |
| 07/12/2001 | WO2001049731A1 A new polypeptide-human protease regulatory protein 9 and the polynucleotide encoding it |
| 07/12/2001 | WO2001049730A1 A novel polypeptide - clathrin light chain 12 and a polynucleotide encoding the same |
| 07/12/2001 | WO2001049729A2 Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use |
| 07/12/2001 | WO2001049728A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 07/12/2001 | WO2001049727A1 A novel polypeptide-bacteria chemotactic signal transducer 9 and the polynucleotide encoding said polypeptide |
| 07/12/2001 | WO2001049726A1 A novel polypeptide-human natriuretic peptide receptor 18 and the polynucleotide encoding said polypeptide |
| 07/12/2001 | WO2001049725A1 A novel polypeptide-sigma-54 factor 13 and the polynucleotide encoding said polypeptide |
| 07/12/2001 | WO2001049724A1 A novel polypeptide-human lissencephaly protein 43 and the polynucleotide encoding said polypeptide |
| 07/12/2001 | WO2001049722A2 New actinobacillus pleuropneumoniae outer membrane protein and its uses |
| 07/12/2001 | WO2001049721A2 Bacterial genes and proteins that are essential for cell viability and their uses |
| 07/12/2001 | WO2001049720A2 Chemically modified hiv envelope glycoprotein |
| 07/12/2001 | WO2001049719A2 Activators of caspases |
| 07/12/2001 | WO2001049717A2 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or t cell subset activity by modulation of xbp-1 activity |
| 07/12/2001 | WO2001049716A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 07/12/2001 | WO2001049715A2 Methods and compositions for inhibiting neoplastic cell growth |
| 07/12/2001 | WO2001049714A2 Nope polypeptides, encoding nucleic acids and methods of use |
| 07/12/2001 | WO2001049713A2 Stabilizing peptides, polypeptides and antibodies which include them |
| 07/12/2001 | WO2001049712A2 Vaccine against isav (infectious salmon anaemia virus) |
| 07/12/2001 | WO2001049711A2 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | WO2001049709A1 Glycogen synthase kinase-3 inhibitors |
| 07/12/2001 | WO2001049708A2 Peptide ligands that mimic sensor kinases and inhibit response regulators |
| 07/12/2001 | WO2001049707A1 Gene involved in mineral deposition and uses thereof |
| 07/12/2001 | WO2001049705A2 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent |
| 07/12/2001 | WO2001049702A1 Epididymal antimicrobial peptides |
| 07/12/2001 | WO2001049318A1 Novel chimeric proteins and methods for using the same |
| 07/12/2001 | WO2001049317A2 Enhancing the immune response to an antigen by presensitizing with an inducing agent prior to immunizing with the inducing agent and the antigen |
| 07/12/2001 | WO2001049312A2 O-superfamily conotoxin peptides |
| 07/12/2001 | WO2001049310A1 C-ski oncogene-derived peptides for prevention, treatment, and diagnosis of cancer |
| 07/12/2001 | WO2001049163A1 Pp14 fusion proteins and methods for making and using the same |
| 07/12/2001 | WO2001049098A2 Alzheimer's disease secretase, app substrates therefor, and uses therefor |
| 07/12/2001 | WO2001049097A2 Alzheimer's disease secretase, app substrates therefor, and uses therefor |
| 07/12/2001 | WO2001023562A9 Osteoprotegerin regulatory region |
| 07/12/2001 | WO2001012665A3 Helical cytokine zalpha48 |
| 07/12/2001 | WO2001008677A8 Methods of inhibiting osteoclast activity |
| 07/12/2001 | WO2001007605A8 Immunosuppression by cell surface expression of recombinant cd154 |
| 07/12/2001 | WO2001004315A3 Ringene compositions and methods for use thereof |
| 07/12/2001 | WO2001004281A3 Dna coding for beta-tubulin and use thereof |
| 07/12/2001 | WO2001004151A3 TUBERCULOSIS VACCINE AND DIAGNOSTICS BASED ON THE MYCOBACTERIUM TUBERCULOSIS esat-6 GENE FAMILY |
| 07/12/2001 | WO2001002425A3 Peptide conjugates for the stabilization of membrane proteins and interactions with biological membranes |
| 07/12/2001 | WO2001002370A9 Nickel-based reagents for detecting dna and dna-protein contacts |
| 07/12/2001 | WO2000076456A3 Modulators of fibrosis |
| 07/12/2001 | WO2000075354A3 Adenoviral vectors encoding interferon and their use in gene therapy |
| 07/12/2001 | WO2000075321A3 Polynucleotides and membrane-bound polypeptide encoded thereby |
| 07/12/2001 | WO2000075278A9 Gene encoding nade, p75ntr-associated cell death executor and uses thereof |
| 07/12/2001 | WO2000074724A3 Conjugates comprising cytokines and nucleic acids for treating proliferating cells |
| 07/12/2001 | WO2000071711A3 Differentially expressed genes in prostate cancer |
| 07/12/2001 | WO2000069391A3 CRYSTAL STRUCTURE OF RIBOSOMAL PROTEIN L11/GTPASE ACTIVATING REGION rRNA AND USES THEREOF |
| 07/12/2001 | WO2000068259A3 Vaccine |
| 07/12/2001 | WO2000061735A9 Modification of plant storage reserves |
| 07/12/2001 | WO2000061230A3 Estrogen receptors-beta antagonism and bone diseases |
| 07/12/2001 | WO2000056144A9 Human sperm surface antigen |
| 07/12/2001 | WO2000055318A8 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 07/12/2001 | WO2000004041A3 Methods and molecules relating to cd39-like polypeptides |
| 07/12/2001 | WO2000000510A3 Growth factor modulators |
| 07/12/2001 | WO1999052541A3 Artery- and vein-specific proteins and uses therefor |
| 07/12/2001 | US20010007901 Process for purifying factor VII and activated factor VII |
| 07/12/2001 | US20010007860 Immunology response |
| 07/12/2001 | US20010007853 By inhalation |
| 07/12/2001 | US20010007768 Colorimetric analysis |
| 07/12/2001 | US20010007767 Genetic engineering |
| 07/12/2001 | US20010007757 Genetic engineering |
| 07/12/2001 | US20010007756 Cosmetic compositions |
| 07/12/2001 | US20010007755 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 07/12/2001 | US20010007752 Genetic engineering; nucleic acids |
| 07/12/2001 | US20010007751 Labeled protein and its producing method, labeling compound to be used in the method, and method for analyzing function of genes |
| 07/12/2001 | US20010007741 Diagnosing sensitivity |
| 07/12/2001 | US20010007674 Stimulate hair growth |
| 07/12/2001 | DE19963859A1 Bi- oder Oligomer eines Di-, Tri-, Quattro- oder Pentamers von rekombinanten Fusionsproteinen Bi- or oligomer of a di-, tri-, Quattro or pentamer of recombinant fusion proteins |
| 07/12/2001 | DE19963612A1 New potassium channel subunit proteins, useful for identifying and testing potential pharmaceuticals, e.g. anti-arrhythmic or neurological agents |
| 07/12/2001 | DE19963420A1 Gewinnung von biologischen Komponenten aus Körperflüssigkeiten Extraction of biological components from body fluids |
| 07/12/2001 | DE19961899A1 Interaktikonsproteine für STAT Transkriptionsfaktor Interaktikonsproteine for STAT transcription factor |
| 07/12/2001 | DE19960500A1 Antikörper und Verfahren zu ihrer Herstellung, deren Verwendung sowie Immunisierungscocktails, Immunoassay-Sets und Peptide Antibodies and methods for their preparation, their use and immunization cocktails, immunoassay kits and peptides |
| 07/12/2001 | DE10064713A1 Preparation of gamma-poly(glutamic acid) using Bacillus species, useful e.g. in foods or cosmetics, includes pH adjustment, centrifuging, concentration and alcohol precipitation |
| 07/12/2001 | CA2654770A1 Increased lysine production by gene amplification |
| 07/12/2001 | CA2397714A1 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent |
| 07/12/2001 | CA2396798A1 Recombinant pinoresinol/lariciresinol reductase, recombinant dirigent protein, and methods of use |
| 07/12/2001 | CA2396696A1 Assays for detection of bacillus anthracis |